Aurora Cannabis Inc (NYSE:ACB) Expected to Earn Q3 2020 Earnings of ($0.01) Per Share

Aurora Cannabis Inc (NYSE:ACB) – Equities research analysts at Seaport Global Securities cut their Q3 2020 earnings per share estimates for shares …

Aurora Cannabis logo

Aurora Cannabis Inc (NYSE:ACB) – Equities research analysts at Seaport Global Securities cut their Q3 2020 earnings per share estimates for shares of Aurora Cannabis in a report released on Tuesday, May 28th, according to Zacks Investment Research. Seaport Global Securities analyst B. Hundley now anticipates that the company will earn ($0.01) per share for the quarter, down from their prior estimate of $0.01. Seaport Global Securities also issued estimates for Aurora Cannabis’ Q4 2020 earnings at $0.01 EPS and FY2021 earnings at $0.04 EPS.

ACB has been the subject of several other research reports. Bank of America started coverage on shares of Aurora Cannabis in a report on Wednesday, April 17th. They issued a “buy” rating and a $11.00 price objective for the company. Desjardins started coverage on shares of Aurora Cannabis in a research report on Thursday, April 25th. They issued a “buy” rating and a $9.07 price target on the stock. Stifel Nicolaus started coverage on shares of Aurora Cannabis in a research report on Wednesday, June 5th. They issued a “hold” rating on the stock. Zacks Investment Research cut shares of Aurora Cannabis from a “hold” rating to a “sell” rating in a research report on Tuesday, May 14th. Finally, TheStreet upgraded shares of Aurora Cannabis from a “d+” rating to a “c” rating in a research report on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Aurora Cannabis has an average rating of “Buy” and an average target price of $9.86.

ACB stock traded down $0.14 during trading on Wednesday, hitting $7.30. The company had a trading volume of 16,148,900 shares, compared to its average volume of 10,209,622. The company has a market capitalization of $7.54 billion, a P/E ratio of 60.83 and a beta of 2.80. Aurora Cannabis has a fifty-two week low of $4.05 and a fifty-two week high of $12.52. The company has a quick ratio of 1.98, a current ratio of 2.37 and a debt-to-equity ratio of 0.10.

A number of institutional investors have recently modified their holdings of the business. ETF Managers Group LLC acquired a new stake in Aurora Cannabis during the 4th quarter worth about $40,454,000. Norges Bank acquired a new stake in Aurora Cannabis during the 4th quarter worth about $30,915,000. TD Asset Management Inc. acquired a new stake in Aurora Cannabis during the 4th quarter worth about $16,657,000. JW Asset Management LLC acquired a new stake in Aurora Cannabis during the 4th quarter worth about $10,734,000. Finally, D. E. Shaw & Co. Inc. acquired a new stake in Aurora Cannabis during the 4th quarter worth about $10,504,000. Hedge funds and other institutional investors own 9.00% of the company’s stock.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Read More: Cost of Capital

Get a free copy of the Zacks research report on Aurora Cannabis (ACB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Q3 2020 EPS Estimates for Aurora Cannabis Inc (TSE:ACB) Lowered by Seaport Global Securities

Aurora Cannabis Inc (TSE:ACB) – Equities researchers at Seaport Global Securities lowered their Q3 2020 earnings per share estimates for Aurora …

Aurora Cannabis logo

Aurora Cannabis Inc (TSE:ACB) – Equities researchers at Seaport Global Securities lowered their Q3 2020 earnings per share estimates for Aurora Cannabis in a research report issued on Tuesday, May 28th, according to Zacks Investment Research. Seaport Global Securities analyst B. Hundley now anticipates that the company will earn ($0.01) per share for the quarter, down from their previous forecast of $0.01. Seaport Global Securities also issued estimates for Aurora Cannabis’ Q4 2020 earnings at $0.01 EPS.

Aurora Cannabis (TSE:ACB) last announced its earnings results on Tuesday, May 14th. The company reported C($0.10) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of C($0.05) by C($0.05). The company had revenue of C$65.15 million during the quarter, compared to analyst estimates of C$68.05 million.

A number of other research firms have also recently commented on ACB. Jefferies Financial Group reissued a “buy” rating and set a C$12.00 price target on shares of Aurora Cannabis in a report on Monday, February 25th. Cowen restated an “outperform” rating and set a C$14.00 target price on shares of Aurora Cannabis in a research report on Tuesday, March 5th. Bank of America reiterated a “buy” rating and issued a C$15.00 price target on shares of Aurora Cannabis in a report on Wednesday, April 17th. Finally, Desjardins reissued a “buy” rating and issued a C$16.50 price objective on shares of Aurora Cannabis in a research note on Friday, April 26th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of C$14.58.

ACB traded down C$0.18 during trading on Wednesday, hitting C$9.65. The stock had a trading volume of 8,448,000 shares, compared to its average volume of 12,773,262. The company has a market capitalization of $9.77 billion and a PE ratio of -38.29. The company has a debt-to-equity ratio of 14.55, a current ratio of 2.37 and a quick ratio of 1.80. Aurora Cannabis has a one year low of C$5.29 and a one year high of C$16.24.

In related news, Senior Officer Allan John Cleiren sold 33,000 shares of Aurora Cannabis stock in a transaction on Monday, April 22nd. The stock was sold at an average price of C$12.12, for a total transaction of C$399,960.00. Following the completion of the sale, the insider now owns 51,120 shares of the company’s stock, valued at C$619,574.40.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Article: How to Invest in Growth Stocks

Get a free copy of the Zacks research report on Aurora Cannabis (ACB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aurora Cannabis (TSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Aurora Cannabis Inc (NYSE:ACB) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.

Sumitomo Mitsui Trust Holdings Inc. grew its stake in shares of Aurora Cannabis Inc (NYSE:ACB) by 1.8% in the 1st quarter, according to its most …

Aurora Cannabis logoSumitomo Mitsui Trust Holdings Inc. grew its stake in shares of Aurora Cannabis Inc (NYSE:ACB) by 1.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,357,247 shares of the company’s stock after buying an additional 42,283 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned 0.23% of Aurora Cannabis worth $21,320,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Moloney Securities Asset Management LLC boosted its holdings in Aurora Cannabis by 13.9% in the first quarter. Moloney Securities Asset Management LLC now owns 12,320 shares of the company’s stock worth $112,000 after purchasing an additional 1,500 shares in the last quarter. Focused Wealth Management Inc boosted its holdings in Aurora Cannabis by 33.6% during the first quarter. Focused Wealth Management Inc now owns 6,574 shares of the company’s stock valued at $60,000 after acquiring an additional 1,654 shares during the period. Farmers & Merchants Trust Co of Chambersburg PA boosted its holdings in Aurora Cannabis by 27.7% during the first quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 9,220 shares of the company’s stock valued at $84,000 after acquiring an additional 2,000 shares during the period. CNB Bank boosted its holdings in Aurora Cannabis by 100.0% during the first quarter. CNB Bank now owns 4,000 shares of the company’s stock valued at $36,000 after acquiring an additional 2,000 shares during the period. Finally, Trustcore Financial Services LLC boosted its holdings in Aurora Cannabis by 34.1% during the first quarter. Trustcore Financial Services LLC now owns 8,880 shares of the company’s stock valued at $80,000 after acquiring an additional 2,258 shares during the period. 9.00% of the stock is owned by institutional investors.

ACB has been the subject of a number of recent analyst reports. ValuEngine upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Tuesday, March 19th. GMP Securities raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Wednesday, March 13th. Jefferies Financial Group initiated coverage on shares of Aurora Cannabis in a research report on Monday, February 25th. They set a “buy” rating for the company. Desjardins began coverage on shares of Aurora Cannabis in a research report on Thursday, April 25th. They set a “buy” rating and a $9.07 price objective for the company. Finally, Bank of America began coverage on shares of Aurora Cannabis in a research report on Wednesday, April 17th. They issued a “buy” rating and a $11.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $9.86.

Shares of NYSE ACB traded down $0.14 during mid-day trading on Friday, hitting $7.30. 16,148,900 shares of the stock were exchanged, compared to its average volume of 10,209,622. The firm has a market cap of $7.54 billion, a price-to-earnings ratio of 60.83 and a beta of 2.80. The company has a current ratio of 2.37, a quick ratio of 1.98 and a debt-to-equity ratio of 0.10. Aurora Cannabis Inc has a twelve month low of $4.05 and a twelve month high of $12.52.

Aurora Cannabis Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: Should I follow buy, hold and sell recommendations?

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Seaport Global Securities Equities Analysts Reduce Earnings Estimates for Aurora Cannabis Inc …

Aurora Cannabis Inc (NYSE:ACB) – Equities research analysts at Seaport Global Securities decreased their FY2019 earnings per share (EPS) …

Aurora Cannabis logo

Aurora Cannabis Inc (NYSE:ACB) – Equities research analysts at Seaport Global Securities decreased their FY2019 earnings per share (EPS) estimates for Aurora Cannabis in a research report issued to clients and investors on Tuesday, May 28th, Zacks Investment Research reports. Seaport Global Securities analyst B. Hundley now forecasts that the company will post earnings per share of ($0.25) for the year, down from their previous forecast of ($0.17). Seaport Global Securities also issued estimates for Aurora Cannabis’ Q4 2019 earnings at ($0.03) EPS, Q1 2020 earnings at ($0.02) EPS, Q2 2020 earnings at ($0.01) EPS and FY2020 earnings at ($0.04) EPS.

A number of other equities analysts also recently commented on ACB. ValuEngine downgraded Aurora Cannabis from a “buy” rating to a “hold” rating in a research note on Saturday. Zacks Investment Research upgraded Aurora Cannabis from a “sell” rating to a “hold” rating in a research note on Monday, May 20th. TheStreet raised Aurora Cannabis from a “d+” rating to a “c” rating in a report on Thursday, April 4th. Stifel Nicolaus initiated coverage on Aurora Cannabis in a report on Wednesday, June 5th. They set a “hold” rating on the stock. Finally, Desjardins initiated coverage on Aurora Cannabis in a report on Thursday, April 25th. They set a “buy” rating and a $9.07 price target on the stock. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $9.86.

ACB stock traded down $0.14 during midday trading on Thursday, reaching $7.30. The company had a trading volume of 16,148,900 shares, compared to its average volume of 10,209,622. The company has a quick ratio of 1.98, a current ratio of 2.37 and a debt-to-equity ratio of 0.10. Aurora Cannabis has a fifty-two week low of $4.05 and a fifty-two week high of $12.52. The company has a market cap of $7.54 billion, a P/E ratio of 60.83 and a beta of 2.80.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Moisand Fitzgerald Tamayo LLC bought a new stake in Aurora Cannabis during the first quarter worth approximately $25,000. Financial Management Professionals Inc. raised its holdings in Aurora Cannabis by 586.3% during the first quarter. Financial Management Professionals Inc. now owns 3,061 shares of the company’s stock worth $28,000 after purchasing an additional 2,615 shares in the last quarter. Carroll Financial Associates Inc. bought a new stake in Aurora Cannabis during the first quarter worth approximately $27,000. Burt Wealth Advisors raised its holdings in Aurora Cannabis by 1,033.3% during the first quarter. Burt Wealth Advisors now owns 3,400 shares of the company’s stock worth $31,000 after purchasing an additional 3,100 shares in the last quarter. Finally, Oakworth Capital Inc. bought a new stake in Aurora Cannabis during the first quarter worth approximately $35,000. 9.00% of the stock is currently owned by institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

See Also: Understanding debt-to-equity ratio in fundamental analysis

Get a free copy of the Zacks research report on Aurora Cannabis (ACB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Aurora Cannabis (TSE:ACB) Stock Price Passes Below 50 Day Moving Average of $10.98

Aurora Cannabis Inc (TSE:ACB)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving …

Aurora Cannabis logoAurora Cannabis Inc (TSE:ACB)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $10.98 and traded as low as $9.81. Aurora Cannabis shares last traded at $9.81, with a volume of 1,952,936 shares trading hands.

Several equities research analysts have commented on ACB shares. Jefferies Financial Group raised their price target on shares of Aurora Cannabis from C$12.00 to C$14.00 in a research note on Friday, May 3rd. Cowen restated an “outperform” rating and issued a C$14.00 price target on shares of Aurora Cannabis in a research note on Tuesday, March 5th. Desjardins restated a “buy” rating and issued a C$16.50 price target on shares of Aurora Cannabis in a research note on Friday, April 26th. Finally, Bank of America restated a “buy” rating and issued a C$15.00 price target on shares of Aurora Cannabis in a research note on Wednesday, April 17th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of C$14.58.

The company has a market cap of $9.77 billion and a P/E ratio of -38.29. The company has a debt-to-equity ratio of 14.55, a quick ratio of 1.80 and a current ratio of 2.37.

Aurora Cannabis (TSE:ACB) last posted its quarterly earnings data on Tuesday, May 14th. The company reported C($0.10) EPS for the quarter, missing the Zacks’ consensus estimate of C($0.05) by C($0.05). The company had revenue of C$65.15 million for the quarter, compared to analyst estimates of C$68.05 million. On average, research analysts forecast that Aurora Cannabis Inc will post -0.06 earnings per share for the current fiscal year.

In related news, Senior Officer Allan John Cleiren sold 33,000 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of C$12.12, for a total transaction of C$399,960.00. Following the transaction, the insider now owns 51,120 shares in the company, valued at C$619,574.40.

About Aurora Cannabis (TSE:ACB)

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Article: What is a portfolio manager?

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts